🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/11/2020 139,62 142,76 138,01 141,40 +1,83% 3,40% 481.900
12/11/2020 134,64 139,90 132,59 138,86 +3,07% 5,43% 693.700
11/11/2020 128,70 134,76 128,70 134,73 +4,95% 4,71% 813.200
10/11/2020 125,35 128,71 122,38 128,38 +2,25% 5,05% 1.069.700
09/11/2020 129,34 130,79 124,12 125,56 -0,08% 5,16% 1.548.000
06/11/2020 139,50 142,88 123,50 125,66 -13,43% 13,89% 4.490.300
05/11/2020 154,14 154,99 144,16 145,15 -4,44% 7,03% 986.300
04/11/2020 143,55 153,97 143,05 151,90 +7,47% 7,61% 934.200
03/11/2020 138,73 142,97 135,70 141,34 +2,95% 5,24% 614.800
02/11/2020 137,05 138,03 133,56 137,29 +1,02% 3,26% 494.500
30/10/2020 140,36 141,53 134,14 135,91 -3,94% 5,27% 723.200
29/10/2020 141,17 141,98 136,66 141,49 +0,83% 3,77% 480.200
28/10/2020 139,22 141,80 137,01 140,33 +0,51% 3,44% 446.600
27/10/2020 139,63 140,91 137,34 139,62 +0,72% 2,56% 440.600
26/10/2020 136,82 140,20 136,00 138,62 +0,65% 3,07% 358.400
23/10/2020 137,41 138,56 135,10 137,73 -0,05% 2,52% 372.400
22/10/2020 138,12 141,32 137,47 137,80 +0,39% 2,79% 512.800
21/10/2020 136,62 139,31 136,24 137,26 -0,17% 2,25% 332.300
20/10/2020 141,91 141,99 137,14 137,50 -2,34% 3,42% 510.800
19/10/2020 143,00 143,70 140,00 140,79 -1,14% 2,59% 291.700
16/10/2020 143,34 145,66 142,26 142,42 -0,63% 2,37% 421.500
15/10/2020 144,11 145,70 141,98 143,33 -1,23% 2,58% 411.000
14/10/2020 147,99 149,65 145,12 145,12 -1,45% 3,06% 418.300
13/10/2020 144,09 147,89 142,37 147,26 +3,07% 3,83% 410.100
12/10/2020 145,22 146,51 142,73 142,87 -0,49% 2,60% 284.000
09/10/2020 144,22 145,99 142,48 143,58 -0,77% 2,43% 309.700
08/10/2020 146,63 146,96 144,26 144,70 -0,80% 1,84% 432.200
07/10/2020 140,00 146,78 139,83 145,86 +4,56% 4,96% 1.136.800
06/10/2020 139,00 140,43 137,90 139,50 +0,50% 1,82% 436.000
05/10/2020 136,05 140,76 136,02 138,80 +2,97% 3,48% 592.900